Bollywood actors Saif Ali Khan Rani Mukerji Siddhant Chaturvedi and debutant Sharvari pose for a photograph after shooting for the film 'Bunty Aur Babli 2' in Mumbai. (File Photo | PTI) 
Entertainment News

Saif Ali Khan gains extra kilos for his role in 'Bunty Aur Babli 2'

Directed by Varun V. Sharma, 'Bunty Aur Babli 2' is a sequel to the 2005 hit film 'Bunty Aur Babli', starring Rani alongside Abhishek Bachchan and Amitabh Bachchan.

ANI

MUMBAI: On Saturday, the makers of 'Bunty Aur Babli 2' unveiled the first look of actors Saif Ali Khan and Rani Mukerji from the film, and it is clearly evident from the posters that Saif has gained weight for his role.

Talking about the same, Saif, who will be seen essaying the role of a railway ticket collector in the movie, said, "I had to put on several kilos and then lose it quickly because of my packed shooting schedule. Now, when I look back, I'm glad I went through the process because Rakesh aka the OG Bunty looks believable in the film. He is a family man, who has quit conning people. He has settled down. He is endearing, his struggles are real. He was a legend and now he is a nobody. He craves to be known and that's what makes him disappointed about how his life has shaped up. He wants to feel important."

In one of the posters, Rani can be seen taking a measure of Saif's large paunch.

Directed by Varun V. Sharma, 'Bunty Aur Babli 2' is a sequel to the 2005 hit film 'Bunty Aur Babli', starring Rani alongside Abhishek Bachchan and Amitabh Bachchan.

The upcoming part, which is scheduled to release on November 19, also stars actors Siddhant Chaturvedi and debutant Sharvari.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’